SecBot SecBot
SECBOTREPLAY Home › Report › HCA

HCA · HCA Healthcare issued preliminary Q2 2026 results and revised 2026…

HCA Healthcare, Inc. · 8-K filed Jul 14, 2026 at 07:40 ET

At the news

BEARISHIMPACT 6/10

8-K filed Jul 14, 2026 at 07:40 ET

HCA Healthcare issued preliminary Q2 2026 results and revised 2026 guidance downward. Q2 revenue grew 8.7% YoY to ~$20.23B and EPS rose to $7.62, but a $400M unfavorable payer mix shift from health insurance exchange losses drove a guidance cut: 2026 EPS guidance lowered to $28.70-$30.50 (from $29.10-$31.50) and net income guidance reduced by ~$195M-$335M at the midpoint. The Medicaid Supplemental Payment Programs provided a $400M offset in Q2, but the net outlook is negative.

  • Preliminary Q2 2026 revenue ~$20.23B (+8.7% YoY), net income ~$1.699B ($7.62 EPS) vs $1.653B ($6.83) in Q2 2025
  • Same facility admissions +2.5%, equivalent admissions +2.7%, ER visits +3.6%
  • Payer mix shift from health insurance exchanges had ~$400M unfavorable impact on Q2 income before taxes
  • Medicaid Supplemental Payment Programs provided ~$400M incremental net benefit in Q2, primarily from Florida

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access